Best-for cards
Guides should explain why each brand is included, who should skip it, and what documentation supports the placement.
The editorial boundary for peptide content, including source verification, regulatory checks, and non-medical-use positioning.
Guides should explain why each brand is included, who should skip it, and what documentation supports the placement.
Affiliate disclosure appears before comparison modules and near outbound CTAs.
Every guide needs original criteria, risk notes, and internal links back to methodology assets.
Content is written for source literacy, regulatory awareness, and vendor-documentation review. It is not medical advice, prescribing guidance, legal advice, or a recommendation to buy or use any product.
High-risk pages require current review of FDA materials, labels when applicable, ClinicalTrials.gov, PubMed-indexed literature, anti-doping context when relevant, and vendor documentation before publication.